BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rusch VW, Rice TW, Crowley J, Blackstone EH, Rami-Porta R, Goldstraw P. The seventh edition of the American Joint Committee on Cancer/International Union Against Cancer Staging Manuals: the new era of data-driven revisions. J Thorac Cardiovasc Surg. 2010;139:819-821. [PMID: 20304130 DOI: 10.1016/j.jtcvs.2010.02.013] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Dikken JL, van de Velde CJ, Coit DG, Shah MA, Verheij M, Cats A. Treatment of resectable gastric cancer. Therap Adv Gastroenterol. 2012;5:49-69. [PMID: 22282708 DOI: 10.1177/1756283x11410771] [Cited by in Crossref: 48] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
2 Reeh M, Nentwich MF, von Loga K, Schade J, Uzunoglu FG, Koenig AM, Bockhorn M, Rosch T, Izbicki JR, Bogoevski D. An attempt at validation of the Seventh edition of the classification by the International Union Against Cancer for esophageal carcinoma. Ann Thorac Surg 2012;93:890-6. [PMID: 22289905 DOI: 10.1016/j.athoracsur.2011.11.035] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
3 Cao CN, Liu SY, Luo JW, Gao L, Xu GZ, Xu ZG, Tang PZ. Pattern of Failure in Surgically Treated Patients with Cervical Esophageal Squamous Cell Carcinoma. Otolaryngol Head Neck Surg 2014;151:260-4. [PMID: 24748589 DOI: 10.1177/0194599814531915] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
4 Mehta SP, Jose P, Mirza A, Pritchard SA, Hayden JD, Grabsch HI. Comparison of the prognostic value of the 6th and 7th editions of the Union for International Cancer Control TNM staging system in patients with lower esophageal cancer undergoing neoadjuvant chemotherapy followed by surgery: Comparison of UICC TNM staging systems. Dis Esophagus 2013;26:182-8. [DOI: 10.1111/j.1442-2050.2012.01350.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
5 Huang Y, Guo W, Shi S, He J. Evaluation of the 7(th) edition of the UICC-AJCC tumor, node, metastasis classification for esophageal cancer in a Chinese cohort. J Thorac Dis 2016;8:1672-80. [PMID: 27499956 DOI: 10.21037/jtd.2016.06.24] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
6 Nagtegaal ID, Quirke P, Schmoll HJ. Has the new TNM classification for colorectal cancer improved care? Nat Rev Clin Oncol. 2012;9:119-123. [PMID: 22009076 DOI: 10.1038/nrclinonc.2011.157] [Cited by in Crossref: 89] [Cited by in F6Publishing: 92] [Article Influence: 8.1] [Reference Citation Analysis]
7 Dikken JL, Coit DG, Klimstra DS, Rizk NP, van Grieken N, Ilson D, Tang LH. Prospective impact of tumor grade assessment in biopsies on tumor stage and prognostic grouping in gastroesophageal adenocarcinoma: Relevance of the seventh edition American Joint Committee on Cancer Staging Manual revision. Cancer 2012;118:349-57. [DOI: 10.1002/cncr.26301] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
8 Murakami M, Otsuka K, Goto S, Ariyoshi T, Yamashita T, Aoki T. Thoracoscopic and hand assisted laparoscopic esophagectomy with radical lymph node dissection for esophageal squamous cell carcinoma in the left lateral decubitus position: a single center retrospective analysis of 654 patients. BMC Cancer 2017;17:748. [PMID: 29126387 DOI: 10.1186/s12885-017-3743-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
9 Serralheiro P, Rankin A, Clark A, Holyoake D, Cheong E. Pre- and postoperative prognostic factors for resectable esophageal adenocarcinoma. Surg Oncol 2020;35:132-8. [PMID: 32871548 DOI: 10.1016/j.suronc.2020.08.026] [Reference Citation Analysis]
10 Lindskog C, Edlund K, Mattsson JSM, Micke P. Immunohistochemistry-based prognostic biomarkers in NSCLC: novel findings on the road to clinical use? Expert Review of Molecular Diagnostics 2015;15:471-90. [DOI: 10.1586/14737159.2015.1002772] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
11 Qin B, Dong M, Wang Z, Wan J, Xie Y, Jiao Y, Yan D. Long non‑coding RNA CASC15 facilitates esophageal squamous cell carcinoma tumorigenesis via decreasing SIM2 stability via FTO‑mediated demethylation. Oncol Rep 2021;45:1059-71. [PMID: 33650646 DOI: 10.3892/or.2020.7917] [Reference Citation Analysis]
12 Rice TW. Staging of esophageal cancer: TNM and beyond. Esophagus 2010;7:189-95. [DOI: 10.1007/s10388-010-0246-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
13 Encinas de la Iglesia J, Corral de la Calle MA, Fernández Pérez GC, Ruano Pérez R, Álvarez Delgado A. Esophageal cancer: anatomic particularities, staging, and imaging techniques. Radiologia 2016;58:352-65. [PMID: 27469407 DOI: 10.1016/j.rx.2016.06.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
14 Otsuka K, Murakami M, Goto S, Ariyoshi T, Yamashita T, Saito A, Kohmoto M, Kato R, Lefor AK, Aoki T. Minimally invasive esophagectomy and radical lymph node dissection without recurrent laryngeal nerve paralysis. Surg Endosc 2020;34:2749-57. [PMID: 32016515 DOI: 10.1007/s00464-020-07372-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
15 Lagarde SM, Phillips AW, Navidi M, Disep B, Griffin SM. Clinical outcomes and benefits for staging of surgical lymph node mapping after esophagectomy. Diseases of the Esophagus 2017;30:1-7. [DOI: 10.1093/dote/dox086] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
16 Hollis AC, Quinn LM, Hodson J, Evans E, Plowright J, Begum R, Mitchell H, Hallissey MT, Whiting JL, Griffiths EA. Prognostic significance of tumor length in patients receiving esophagectomy for esophageal cancer. J Surg Oncol 2017;116:1114-22. [PMID: 28767142 DOI: 10.1002/jso.24789] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
17 Bott RK, George G, McEwen R, Zylstra J, Knight WRC, Baker CR, Kelly M, Griffin N, McAddy N, Maisey N, Van Hemelrijck M, Gossage JA, Lagergren J, Davies AR. Predicting response to neoadjuvant chemotherapy in patients with oesophageal adenocarcinoma. Acta Oncol 2021;:1-8. [PMID: 34613874 DOI: 10.1080/0284186X.2021.1986228] [Reference Citation Analysis]
18 Guo W, Xiao H, Ma Z, Liu H, Wang Y, Mei L, Liu X, Jiang Y, Wang R. Should Stage T2 Esophageal Squamous Cell Carcinoma Be Subclassified? Ann Surg Oncol 2014;21:2540-5. [DOI: 10.1245/s10434-014-3636-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
19 Talsma K, van Hagen P, Grotenhuis BA, Steyerberg EW, Tilanus HW, van Lanschot JJ, Wijnhoven BP. Comparison of the 6th and 7th Editions of the UICC-AJCC TNM Classification for Esophageal Cancer. Ann Surg Oncol. 2012;19:2142-2148. [PMID: 22395974 DOI: 10.1245/s10434-012-2218-5] [Cited by in Crossref: 109] [Cited by in F6Publishing: 107] [Article Influence: 10.9] [Reference Citation Analysis]
20 Sakai M, Sohda M, Saito H, Ubukata Y, Nakazawa N, Kuriyama K, Hara K, Sano A, Ogata K, Yokobori T, Shirabe K, Saeki H. Comparative Analysis of Immunoinflammatory and Nutritional Measures in Surgically Resected Esophageal Cancer: A Single-center Retrospective Study. In Vivo 2020;34:881-7. [PMID: 32111799 DOI: 10.21873/invivo.11853] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Al-haddad S, Chang AC, De Hertogh G, Grin A, Langer R, Sagaert X, Salemme M, Streutker CJ, Soucy G, Tripathi M, Upton MP, Vieth M, Villanacci V. Adenocarcinoma at the gastroesophageal junction: Adenocarcinoma at the gastroesophageal junction. Ann N Y Acad Sci 2014;1325:211-25. [DOI: 10.1111/nyas.12535] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
22 Raja S, Rice TW, Murthy SC, Ahmad U, Semple ME, Blackstone EH, Ishwaran H; Worldwide Esophageal Cancer Collaboration Investigators. Value of Lymphadenectomy in Patients Receiving Neoadjuvant Therapy for Esophageal Adenocarcinoma. Ann Surg 2021;274:e320-7. [PMID: 31850981 DOI: 10.1097/SLA.0000000000003598] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
23 Thomaschewski M, Hummel R, Petrova E, Knief J, Wellner UF, Keck T, Bausch D. Impact of postoperative TNM stages after neoadjuvant therapy on prognosis of adenocarcinoma of the gastro-oesophageal junction tumours. World J Gastroenterol 2018; 24(13): 1429-1439 [PMID: 29632424 DOI: 10.3748/wjg.v24.i13.1429] [Reference Citation Analysis]
24 Rice TW. 7th Edition AJCC/UICC Staging: Esophagus and Esophagogastric Junction. In: Giacopuzzi S, Zanoni A, de Manzoni G, editors. Adenocarcinoma of the Esophagogastric Junction. Cham: Springer International Publishing; 2017. pp. 41-6. [DOI: 10.1007/978-3-319-28776-8_6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
25 Kleinberg L. Therapy for locally advanced adenocarcinoma of the gastroesophageal junction: optimizing outcome. Semin Radiat Oncol. 2013;23:38-50. [PMID: 23207046 DOI: 10.1016/j.semradonc.2012.10.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
26 Herbella FAM, Laurino Neto RM, Allaix ME, Patti MG. Extended Lymphadenectomy in Esophageal Cancer is Debatable. World J Surg 2013;37:1757-67. [DOI: 10.1007/s00268-013-2018-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
27 Schroeder SR, Leenders M, Iyengar P, de Ruysscher D. Changing equipoise in the landscape of radiation for oligometastatic lung cancer. Transl Lung Cancer Res 2019;8:S184-91. [PMID: 31673523 DOI: 10.21037/tlcr.2019.07.09] [Reference Citation Analysis]
28 Joosten PJM, de Langen AJ, van der Noort V, Monkhorst K, Klomp HM, Veenhof AAFA, Dickhoff C, Smit EF, Hartemink KJ. The role of surgery in the treatment of oligoprogression after systemic treatment for advanced non-small cell lung cancer. Lung Cancer 2021;161:141-51. [PMID: 34600405 DOI: 10.1016/j.lungcan.2021.09.019] [Reference Citation Analysis]
29 Rice TW, Blackstone EH. Esophageal cancer staging: past, present, and future. Thorac Surg Clin. 2013;23:461-469. [PMID: 24199696 DOI: 10.1016/j.thorsurg.2013.07.004] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
30 Jing C, Li H, Du Y, Cao H, Liu S, Wang Z, Ma R, Feng J, Wu J. MEK inhibitor enhanced the antitumor effect of oxaliplatin and 5‑fluorouracil in MEK1 Q56P‑mutant colorectal cancer cells. Mol Med Rep 2019;19:1092-100. [PMID: 30535504 DOI: 10.3892/mmr.2018.9730] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
31 Rochigneux P, Resbeut M, Rousseau F, Bories E, Raoul JL, Poizat F, Moureau-Zabotto L. Radio(chemo)therapy in Elderly Patients with Esophageal Cancer: A Feasible Treatment with an Outcome Consistent with Younger Patients. Front Oncol 2014;4:100. [PMID: 24860783 DOI: 10.3389/fonc.2014.00100] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
32 Quinn LM, Hollis AC, Hodson J, Elshafie MA, Hallissey MT, Whiting JL, Griffiths EA. Prognostic significance of circumferential resection margin involvement in patients receiving potentially curative treatment for oesophageal cancer. Eur J Surg Oncol 2018;44:1268-77. [PMID: 29843937 DOI: 10.1016/j.ejso.2018.05.017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
33 Park M, Shim M, Kim M, Song C, Kim CS, Ahn H. Prognostic heterogeneity in T3aN0M0 renal cell carcinoma according to the site of invasion. Urol Oncol 2017;35:458.e17-22. [PMID: 28476528 DOI: 10.1016/j.urolonc.2016.05.019] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
34 Nowak AK, Chansky K, Rice DC, Pass HI, Kindler HL, Shemanski L, Billé A, Rintoul RC, Batirel HF, Thomas CF, Friedberg J, Cedres S, de Perrot M, Rusch VW;  Staging and Prognostic Factors Committee; Advisory Boards and Participating Institutions. The IASLC Mesothelioma Staging Project: Proposals for Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural Mesothelioma.J Thorac Oncol. 2016;11:2089-2099. [PMID: 27687963 DOI: 10.1016/j.jtho.2016.08.147] [Cited by in Crossref: 73] [Cited by in F6Publishing: 72] [Article Influence: 12.2] [Reference Citation Analysis]
35 Hatogai K, Fujii S, Kojima T, Daiko H, Kadota T, Fujita T, Yoshino T, Doi T, Takiguchi Y, Ohtsu A. Prognostic significance of tumor regression grade for patients with esophageal squamous cell carcinoma after neoadjuvant chemotherapy followed by surgery. J Surg Oncol 2016;113:390-6. [PMID: 27100024 DOI: 10.1002/jso.24151] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
36 Rice TW. Esophageal Cancer Staging. Korean J Thorac Cardiovasc Surg 2015;48:157-63. [PMID: 26078921 DOI: 10.5090/kjtcs.2015.48.3.157] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
37 Depypere LP, Moons J, Mariette C, D’journo XB, Thomas PA, Hölscher AH, Bollschweiler E, van Berge-henegouwen MI, Van Lanschot JJB, Lerut TEMR, Nafteux PR. Impact of Extracapsular Lymph Node Involvement After Neoadjuvant Chemoradiation Therapy Followed by Surgery in Carcinoma of the Esophagus: A Multicenter Study. Annals of Surgery 2018;268:1000-7. [DOI: 10.1097/sla.0000000000002425] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
38 Duan J, Deng T, Ying G, Zhang H, Zhou L, Bai M, Li H, Ba Y. Prognostic significance of the T2 substage in patients with esophageal squamous cell carcinoma. Dis Esophagus 2017;30:1-7. [PMID: 28375473 DOI: 10.1093/dote/dow027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
39 Tumati V, Iyengar P. The current state of oligometastatic and oligoprogressive non-small cell lung cancer. J Thorac Dis 2018;10:S2537-44. [PMID: 30206497 DOI: 10.21037/jtd.2018.07.19] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
40 Wang J, Wu N, Zheng QF, Yan S, Lv C, Li SL, Yang Y. Evaluation of the 7th edition of the TNM classification in patients with resected esophageal squamous cell carcinoma. World J Gastroenterol 2014; 20(48): 18397-18403 [PMID: 25561808 DOI: 10.3748/wjg.v20.i48.18397] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
41 Gao C, Li M, Jiang AL, Sun R, Jin HL, Gui HW, Xiao F, Ding XW, Fu ZM, Feng JP. Overexpression of the mitochondrial chaperone tumor necrosis factor receptor-associated protein 1 is associated with the poor prognosis of patients with colorectal cancer. Oncol Lett 2018;15:5451-8. [PMID: 29552185 DOI: 10.3892/ol.2018.8042] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
42 Kamarajah SK, Navidi M, Wahed S, Immanuel A, Hayes N, Griffin SM, Phillips AW. Significance of Neoadjuvant Downstaging in Carcinoma of Esophagus and Gastroesophageal Junction. Ann Surg Oncol 2020;27:3182-92. [PMID: 32201923 DOI: 10.1245/s10434-020-08358-0] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
43 Ayan AK, Erdemci B, Orsal E, Bayraktutan Z, Akpinar E, Topcu A, Turkeli M, Seven B. Is there any correlation between levels of serum ostepontin, CEA, and FDG uptake in lung cancer patients with bone metastasis? Rev Esp Med Nucl Imagen Mol 2016;35:102-6. [PMID: 26521996 DOI: 10.1016/j.remn.2015.09.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
44 Jiang H, Zhu M, Li Y, Li Q. Association between EGFR exon 19 or exon 21 mutations and survival rates after first-line EGFR-TKI treatment in patients with non-small cell lung cancer. Mol Clin Oncol 2019;11:301-8. [PMID: 31384460 DOI: 10.3892/mco.2019.1881] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
45 Wang C, Cheng JC, Tsai C, Lee J, Huang P, Lin C, Hsu C, Hsieh M, Chang Y, Hsu F. Pathological stage after neoadjuvant chemoradiation and esophagectomy superiorly predicts survival in patients with esophageal squamous cell carcinoma. Radiotherapy and Oncology 2015;115:9-15. [DOI: 10.1016/j.radonc.2015.03.019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]